Boston Trust Walden Corp has reduced its stake in Qualys (QLYS), selling 93,512 shares valued at approximately $10.36 million in the first quarter of 2026. This divestment led to a significant decline in the value of the fund’s investment in Qualys, which fell by $57.95 million quarter-over-quarter, reflecting both the sale and share price movements. Following this transaction, Qualys now represents just 0.73% of Boston Trust Walden’s reportable assets under management.
The reduction in holdings comes as Qualys faces challenges, with its stock down over 31% year-over-year, significantly underperforming the S&P 500. Despite these struggles, the company has recently launched AI-driven solutions aimed at enhancing its cybersecurity offerings, which could signal a potential turnaround. Investors will be closely watching Qualys’ upcoming earnings report on May 5, 2026, where management projects revenue growth of 7% to 8% for the year.
For market professionals, this move by Boston Trust Walden underscores the cautious sentiment surrounding cybersecurity stocks amid competitive pressures and evolving technology landscapes.
Source: fool.com